The rising obesity epidemic in India
Overweight and obesity are becoming more and more common in India, affecting not only adults but also youngsters. The regional…
Overweight and obesity are becoming more and more common in India, affecting not only adults but also youngsters. The regional…
Union Minister Dr. Jitendra Singh, who holds multiple key positions including Minister of State for Science and Technology, recently chaired…
US pharmaceutical giant Eli Lilly has introduced Mounjaro (Tirzepatide) in India, following approval from the Central Drugs Standard Control Organization…
Eli Lilly’s Mounjaro has emerged as the leading choice in the UK’s private obesity drug market, outperforming Novo Nordisk’s Wegovy…
Novo Nordisk’s team in India is asking the company’s global leaders to launch its weight-loss drug Wegovy earlier than planned….